$28.88
0.712.52%
Last update: Oct 28, 4:41 AM
Immunovant Inc (IMVT) Stock Price, Quote, News & History
IMVTNASDAQ
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Immunovant has a consensus price target of $41.88.
The stock price for Immunovant (NASDAQ: IMVT) is $28.99 last updated October 28, 2026 at 4:41 AM EDT.
There are no upcoming dividends for Immunovant.
Immunovant does not have any upcoming earnings scheduled.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to...
